Moset 5 mg/5 ml (Syrup)
60 ml bottle: ৳ 25.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Cetirizine hydrochloride |
| Company | Monicopharma ltd |
| Also available as |
Indications
- Relief of symptoms associated with seasonal & perennial allergic rhinitis
- Treatment of uncomplicated skin manifestations of chronic idiopathic urticaria
- Treatment of allergen induced asthma
Pharmacology
- Potent H1 receptor antagonist
- No significant anticholinergic and antiserotonic effects
- Inhibition of histamine-mediated early phase of allergic reaction
- Reduction in migration of inflammatory cells
- Reduction in release of mediators associated with late phase of allergic reaction
- Peak plasma concentration of Cetirizine 10mg
- Plasma half-life of approximately 11 hours
- Renal clearance of 30 ml/minute
Dosage & Administration
- Adult dosage: 1 tablet or 2 teaspoonfuls daily
- Children 6 years and older dosage: 1 teaspoonful twice daily
- Children 2-6 years dosage: 1 teaspoonful once daily
- Children 6 months to 2 years dosage: 1/2 teaspoonful once daily
- Recommended dosage for intravenous administration in adults and adolescents
- Recommended dosage for intravenous administration in children 6 to 11 years
- Recommended dosage for intravenous administration in children 6 months to 5 years
Interaction
- No clinically significant drug interactions with Theophylline
- No clinically significant drug interactions with Azithromycin
- No clinically significant drug interactions with Pseudoephedrine
- No clinically significant drug interactions with Ketoconazole
- No clinically significant drug interactions with Erythromycin
Contraindications
- Contraindicated in patients with history of hypersensitivity to Cetirizine or hydroxyzine
Side Effects
- Most common side effect: Somnolence
Pregnancy & Lactation
- US FDA Pregnancy Category: B
- Caution during pregnancy if clearly needed
- Cetirizine excreted in human milk
- Caution during lactation
Precautions & Warnings
- Caution when driving or operating heavy machinery
Use in Special Populations
- Reduction in total body clearance of Moset in patients with mild to moderate hepatic and renal impairment
- Safety demonstrated in pediatric patients aged 6 months to 5 years
- Reduction in clearance in elderly patients
Therapeutic Class
- Sedating Anti-histamine
Storage Conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children